GO FUND IT NOW

UNIVERSITY OF TEXAS HLTH SCIENCE CENTER

Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress

Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress is a funding opportunity from UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, up to 39646, closing March 13, 2030.

Funder
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Funding
39646
Deadline
Mar 13, 2030
(1321d left)

Overview

Project Summary Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death in the world and is the fastest growing cause of liver cancer death in the United States. The prognosis of advanced HCC is exceedingly dismal, with a median survival rate of about 10 months. Despite the administration of several…

Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | Go Fund It Now